Pure Global

Eyefresh Tear - Vietnam Registration 240000924/PCBB-HN

Access comprehensive regulatory information for Eyefresh Tear in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000924/PCBB-HN and manufactured by MERACINE Pharmaceutical Research and Manufacturing Corporation. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN DƯỢC PHẨM TÍN PHONG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240000924/PCBB-HN
Registration Details
Vietnam MOH Registration: 240000924/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Eyefresh Tear
VN: Nước mắt nhân tạo Eyefresh Tear
Nước mắt nhân tạo Eyefresh Tear
Risk Class TTBYT Loại B

Registration Details

240000924/PCBB-HN

000.00.19.H26-240419-0019

Artificial Tears

Company Information

CÔNG TY CỔ PHẦN DƯỢC PHẨM TÍN PHONG

Technical Details

- Artificial tears, providing moisture to the eyes and relieving eye discomfort. It creates a cool and refreshing sensation, alleviating fatigue and enhancing the clarity and comfort of the eyes. - It soothes the temporary burning, irritation, and discomfort caused by dry eyes or prolonged exposure to electronic devices (cell phones, computers, TVs), living in an environment polluted by smoke and dust, working in air-conditioned rooms for extended periods, and frequent exposure to sunlight and artificial light sources. - It helps prevent and alleviate symptoms such as dry eyes, eye fatigue, eye pain, itchy eyes, blurred vision, watering eyes, and a foreign body sensation in the eyes. - It lubricates and moisturizes contact lenses, reducing the dryness, discomfort, and irritation associated with their use.

Dates and Status

Apr 25, 2024